-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$16.1529.72% Upside
Third Harmonic Bio, Inc. Frequently Asked Questions
-
What analysts cover Third Harmonic Bio, Inc.?
Third Harmonic Bio, Inc. has been rated by research analysts at Morgan Stanley, Stifel Nicolaus, Raymond James, Jefferies in the past 90 days.